Kolmar Korea Co., Ltd. Share Price

Equities

A161890

KR7161890009

Personal Products

End-of-day quote Korea S.E. 23:00:00 20/05/2024 BST 5-day change 1st Jan Change
57,500 KRW +6.09% Intraday chart for Kolmar Korea Co., Ltd. +7.28% +7.28%

Financials

Sales 2024 * 2,466B 1.81B 142B Sales 2025 * 2,672B 1.96B 154B Capitalization 1,357B 995M 78.44B
Net income 2024 * 90B 65.97M 5.2B Net income 2025 * 125B 91.62M 7.22B EV / Sales 2024 * 0.87 x
Net Debt 2024 * 780B 572M 45.08B Net Debt 2025 * 639B 468M 36.94B EV / Sales 2025 * 0.75 x
P/E ratio 2024 *
14.5 x
P/E ratio 2025 *
11 x
Employees 1,068
Yield 2024 *
1.15%
Yield 2025 *
1.22%
Free-Float 63.36%
More Fundamentals * Assessed data
Dynamic Chart
1 day+6.09%
1 week+7.28%
Current month+14.54%
1 month+16.40%
3 months+17.35%
6 months+17.59%
Current year+7.28%
More quotes
1 week
51 900.00
Extreme 51900
57 700.00
1 month
47 950.00
Extreme 47950
57 700.00
Current year
43 150.00
Extreme 43150
57 700.00
1 year
37 450.00
Extreme 37450
60 700.00
3 years
32 250.00
Extreme 32250
62 800.00
5 years
30 450.00
Extreme 30450
65 400.00
10 years
30 450.00
Extreme 30450
131 500.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 30/09/12
Compliance Officer 44 -
Director/Board Member 51 -
Members of the board TitleAgeSince
Chief Executive Officer 64 30/09/12
Director/Board Member 66 -
Director/Board Member 51 -
More insiders
Date Price Change Volume
21/05/24 57,500 +6.09% 597,804
20/05/24 54,200 +2.46% 207,996
17/05/24 52,900 -1.12% 115,422
16/05/24 53,500 -0.19% 183,127
14/05/24 53,600 -2.55% 367,271

End-of-day quote Korea S.E., May 20, 2024

More quotes
Kolmar Korea Co Ltd is a Korea-based company principally engaged in the manufacture and distribution of cosmetics. The Company operates its business through three segments. The Cosmetics segment is mainly engaged in the business of original development and design manufacturing (ODM) and original equipment manufacturing (OEM) of cosmetics including skin care, makeup, hair care, body care and others. The Pharmaceutical segment develops and manufactures pharmaceuticals and quasi-drugs including ointment creams, oral solutions, external preparations, and solid preparations. The Food segment is involved in the production and sale of health functional food. The Company is also involved in the rental business. The Company distributes its products in domestic and overseas markets.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
57,500 KRW
Average target price
68,625 KRW
Spread / Average Target
+19.35%
Consensus
  1. Stock Market
  2. Equities
  3. A161890 Stock